Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
NIDA Home > NIDA Science & Practice Perspectives

NIDA Science & Practice Perspectives

Volume 3, Number 2 - April 2007

Reference Article Abstracts

Imaging the Addicted Human Brain
[PDF - 1.8MB]
Joanna S. Fowler, Ph.D., Nora D. Volkow, M.D., Cheryl A. Kassed, Ph.D., M.S.P.H., and Linda Chang, M.D.

Bechara, A., et al., 1994. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50(1-3):7-15. Abstract Available

Bechara, A., et al., 2001. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39(4):376-389.

Bendszus, M., et al., 2001. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: Correlation with clinical and neuropsychological data. American Journal of Neuroradiology 22(10):1926-1932. Full Text Available pdf

Birken, D.L., and Oldendorf, W.H., 1989. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neuroscience and Biobehavioral Reviews 13(1):23-31.

Bolla, K.I., et al., 2003. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 19(3):1085-1094.

Brand, A.; Richter-Landsberg, C.; and Leibfritz, D., 1993. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience 15(3-5):289-298. Abstract Available

Breiter, H.C., et al., 1997. Acute effects of cocaine on human brain activity and emotion. Neuron 19(3):591-611.

Breiter, H.C., and Rosen, B.R., 1999. Functional magnetic resonance imaging of brain reward circuitry in the human. Annals of the New York Academy of Sciences 877:523-547. Abstract Available

Brodie, J.D., et al., 2005. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55(2):122-125. Abstract Available

Brody, A.L., et al., 2004. Smoking-induced ventral striatum dopamine release. American Journal of Psychiatry 161(7):1211-1218.

Castagnoli, K., et al., 2002. Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase. Neurotoxicity Research 4(2):151-160. Abstract Available

Chang, L., et al., 1999. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users. American Journal of Psychiatry 156(5):716-722.

Chang, L., et al., 2005a. Enlarged striatum in abstinent methamphetamine abusers: possible compensatory response. Biological Psychiatry 57(9):967-974.

Chang, L., et al., 2005b. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. American Journal of Psychiatry 162(2):361-369.

Daurignac, E., et al., 2005. Applications of morphometric and diffusion tensor magnetic resonance imaging to the study of brain abnormalities in the alcoholism spectrum. Alcoholism: Clinical and Experimental Research 29(1):159-166.

De Vries, T.J., et al., 2001. A cannabinoid mechanism in relapse to cocaine seeking. Nature Medicine 7(10):1151-1154. Full Text Available pdf

Di Chiara, G., 1999. Drug addiction as dopamine-dependent associative learning disorder. European Journal of Pharmacology 375(1-3):13-30. Abstract Available

Di Chiara, G., and Imperato, A., 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the USA 85(14):5274-5278. Full Text Available

Di Ciano, P., and Everitt, B.J., 2003. The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28(3):510-518. Full Text Available pdf

Drevets, W.C., et al., 2001. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biological Psychiatry 49(2):81-96.

Ernst, T., et al., 2000. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology 54(6):1344-1349. Abstract Available

Eslinger, P.J., et al., 1992. Developmental consequences of childhood frontal lobe damage. Archives of Neurology 49(7):764-769. Abstract Available

Fein, G., et al., 2002. Cortical gray matter loss in treatment-naïve alcohol dependent individuals. Alcoholism: Clinical and Experimental Research 26(4):558-564.

Fowler, J.S.; Ding, Y.S.; and Volkow, N.D., 2003. Radiotracers for positron emission tomography imaging. Seminars in Nuclear Medicine 33(1):14-27. Abstract Available

Fowler, J.S., et al., 1996a. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379(6567):733-736. Abstract Available

Fowler, J.S., et al., 1996b. Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Sciences of the USA 93(24):14065-14069. Full Text Available

Fowler, J.S., et al., 1999. PET and drug research and development. Journal of Nuclear Medicine 40(7):1154-1163. Full Text Available

Fowler, J.S., and Ido, T., 2002. Initial and subsequent approach for the synthesis of 18FDG. Seminars in Nuclear Medicine 32(1):6-12. Abstract Available

Fowler, J.S., et al., 2003a. Monoamine oxidase and cigarette smoking. Neurotoxicology 24(1):75-82.

Fowler, J.S., et al., 2005. Comparison of monoamine oxidase A in peripheral organs in nonsmokers and smokers. Journal of Nuclear Medicine 46(9):1414-1420. Full Text Available pdf

George, T.P., et al., 2003. A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biological Psychiatry 53(2):136-143.

Gonzalez, G., et al., 2003. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: Results of a randomized pilot study. Addiction 98(11):1625-1632. Abstract Available

Grabowski, J., et al., 1997. Replacement medication for cocaine dependence: Methylphenidate. Journal of Clinical Psychopharmacology 17(6):485-488.

Gruber, S.A., et al., 2006. Methadone maintenance improves cognitive performance after two months of treatment. Experimental and Clinical Psychopharmacology 14(2)157-164. Abstract Available

Guillem, K., et al., 2006. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. European Journal of Neuroscience 24(12):3532-3540. Abstract Available

Gur, R.E., et al., 1998. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. American Journal of Psychiatry 155(12):1711-1717.

Hariri, A.R., et al., 2002. Serotonin transporter genetic variation and the response of the human amygdala. Science 297(5580):400-403. Full Text Available pdf

Hetherington, H.P., et al., 1999. Spectroscopic imaging of the uptake kinetics of human brain ethanol. Magnetic Resonance in Medicine 42(6):1019-1026. Abstract Available

Hill, S.Y., et al., 2001. Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. Biological Psychiatry 49(11)894-905.

Huang, H., et al., 2006. White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage 33(1):27-38.

Jacobsen, L.K., et al., 2001. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. American Journal of Psychiatry 158(3):486-489.

Jernigan, T.L., et al., 2005. Effects of methamphetamine dependence and HIV infection on cerebral morphology. American Journal of Psychiatry 162(8):1461-1472. Full Text Available pdf

Johnson, B.A., et al., 2003. Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 361(9370):1677-1685.

Julian, M.D., et al., 2003. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience 119(1):309-318.

Kaufman, J.N., et al., 2003. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. Journal of Neuroscience 23(21):7839-7843. Full Text Available pdf

Khalil, A.A.; Steyn, S.; and Castagnoli, N., Jr., 2000. Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chemical Research in Toxicology 13(1):31-35. Abstract Available

Kim, S.J., et al., 2005. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. International Journal of Neuropsychopharmacology 9(2):221-228.

Kosten, T.R., et al., 2006. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31(3):644-650. Abstract Available

Kreek, M.J.; LaForge, K.S.; and Butelman, E., 2002. Pharmacotherapy of addictions. Nature Reviews Drug Discovery 1(9):710-726. Abstract Available

Kufahl, P.R., et al., 2005. Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 28(4):904-914.

Kung, H.F.; Kung, M.P.; and Choi, S.R., 2003. Radiopharmaceuticals for single-photon emission computed tomography brain imaging. Seminars in Nuclear Medicine 33(1):2-13. Abstract Available

Laruelle, M., et al., 1995. SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine 36(7):1182-1190. Full Text Available pdf

Leshner, A.I., 1997. Addiction is a brain disease, and it matters. Science 278(5335):45-47. Abstract Available

Liu, X., et al., 1998. Smaller volume of prefrontal lobe in polysubstance abusers: A magnetic resonance imaging study. Neuropsychopharmacology 18(4):243-252. Abstract Available

Mann et al., 2001. Neuroimaging in alcoholism: Ethanol and brain damage. Alcoholism, Clinical and Experimental Research 25(5):104S-109S.

Matochik, J.A., et al., 2003. Frontal cortical tissue composition in abstinent cocaine abusers: A magnetic resonance imaging study. Neuroimage 19(3):1095-1102.

Mattay, V.S., et al., 2003. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the USA 100(10):6186-6191. Full Text Available pdf

Morens, D.M., et al., 1995. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 45(6):1041-1051. Abstract Available

Neeb, H.; Zilles, K.; and Shah, N.J., 2005. Fully automated detection of cerebral water content changes: Study of age- and gender-related H2O patterns with quantitative MRI. Neuroimage 29(3):910-922.

O'Neill, J.; Cardenas, V.A.; and Meyerhoff, D., 2001. Effects of abstinence on the brain: Quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. Alcoholism: Clinical and Experimental Research 25(11):1673-1682.

Paulus, M.P., et al., 2002. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26(1):53-63. Full Text Available pdf

Paulus, M.P.; Tapert, S.F.; and Schuckit, M.A., 2005. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Archives of General Psychiatry 62(7):761-768. Abstract Available

Pfefferbaum, A., et al., 1995. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcoholism, Clinical and Experimental Research 19(5):1177-1191. Abstract Available

Pfefferbaum, A., et al., 1998. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Archives of General Psychiatry 55(10):905-912. Abstract Available

Pfefferbaum, A., and Sullivan, E.V., 2005. Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: Evidence from diffusion tensor imaging. Neuropsychopharmacology 30(2):423-432. Full Text Available pdf

Rae, C., et al., 1998. Metabolic abnormalities in developmental dyslexia detected by 1H magnetic resonance spectroscopy. Lancet 351(9119):1849-1852.

Raichle, M.E., et al., 1983. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. Journal of Nuclear Medicine 24(9):790-798. Full Text Available

Rinne, J.O., et al., 1995. PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease. Synapse 21(2):97-103. Abstract Available

Risinger, R.C., et al., 2005. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26(4):1097-1108.

Ross, B.; Kreis, R.; and Ernst, T., 1992. Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolite imaging. European Journal of Radiology 14(2):128-140. Abstract Available

Schlaepfer, T.E., et al., 2006. Decreased frontal white-matter volume in chronic substance abuse. International Journal of Neuropsychopharmacology 9(2):147-153.

Silveri, M.M., et al., 2004. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Research 131(3):216-226.

Smith, L.M., et al., 2001a. Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. Pediatrics 107(2):227-231. Full Text Available

Smith, L.M., et al., 2001b. Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology 57(2):255-260. Abstract Available

Stapleton, J.M., et al., 1995. Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology 13(1):21-31. Abstract Available

Thompson, P.M., et al., 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience 24(26):6028-6036. Abstract Available

Volkow, N.D., et al., 1990. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. American Journal of Psychiatry 147(6):719-724.

Volkow, N.D., et al., 1991. Changes in brain glucose metabolism in cocaine dependence and withdrawal. American Journal of Psychiatry 148(5):621-626.

Volkow, N.D., et al., 1993. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14(2):169-177. Abstract Available

Volkow, N.D., et al., 1995. A new PET ligand for the dopamine transporter: Studies in the human brain. Journal of Nuclear Medicine 36(12):2162-2168. Full Text Available pdf

Volkow, N.D., et al., 1996a. PET evaluation of the dopamine system of the human brain. Journal of Nuclear Medicine 37(7):1242-1256. Full Text Available pdf

Volkow, N.D., et al., 1996b. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcoholism, Clinical and Experimental Research 20(9):1594-1598. Abstract Available

Volkow, N.D., et al., 1997. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386(6627):827-830. Abstract Available

Volkow, N.D., et al., 1999. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. Journal of Pharmacology and Experimental Therapeutics 291(1):409-415. Full Text Available pdf

Volkow, N.D., et al., 2001a. Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. American Journal of Psychiatry 158(12):2015-2021.

Volkow, N.D., et al., 2001b. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry 158(3):377-382.

Volkow, N.D., et al., 2004. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Molecular Psychiatry 9(6):557-569. Abstract Available

Volkow, N.D.; Fowler, J.S.; and Wang, G.J., 2003a. Positron emission tomography and single-photon emission computed tomography in substance abuse research. Seminars in Nuclear Medicine 33(2):114-128.

Volkow, N.D.; Fowler, J.S.; and Wang, G.J., 2003b. The addicted human brain: Insights from imaging studies. Journal of Clinical Investigation 111(10):1444-1451. Full Text Available pdf

Volkow, N.D.; Fowler, J.S.; and Wang, G.J., 2004. The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology 47(Suppl 1):3-13.

Wang, G.J., et al., 1997. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16(2):174-182. Full Text Available pdf

Wang, G.J., et al., 2004. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. American Journal of Psychiatry 161(2):242-248. Full Text Available pdf

Warner, T.D., et al., 2006. Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics 118(5):2014-2024. Abstract Available

Wexler, B.E., et al., 2001. Functional magnetic resonance imaging of cocaine craving. American Journal of Psychiatry 158(1):86-95.

Wong, D.F., et al., 1993. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428. Synapse 15(2):130-142. Abstract Available

Zubieta, J.K., et al., 1996. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nature Medicine 2(11):1225-1229. Abstract Available

[PDF - 80K]

London, E.D., et al., 2004. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry 61(1):73-84. Abstract Available

Wang, G.-J., et al., 2004. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. American Journal of Psychiatry 161(2):242-248.

Assessing Organizational Functioning as a Step Toward Innovation
[PDF - 204K]
D. Dwayne Simpson, Ph.D., and Donald F. Dansereau, Ph.D.

Backer, T.E., 1995. Assessing and enhancing readiness for change: Implications for technology transfer. In T.E. Backer, S.L. David, and G. Soucy (Eds.), Reviewing the Behavioral Science Knowledge Base on Technology Transfer (NIDA Research Monograph 155, NIH Publication No. 95-4035). Rockville, MD: National Institute on Drug Abuse. Full Text Available (Archive) pdf

Brown, B.S., and Flynn, P.M., 2002. The federal role in drug abuse technology transfer: A history and perspective. Journal of Substance Abuse Treatment 22(4):245-257.

Dansereau, D.F., 1995. Derived structural schemas and the transfer of knowledge. In A. McKeough, J. Lupart, and A. Marini (Eds.), Teaching for Transfer: Fostering Generalization in Learning (pp. 93-121). Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.

Dansereau, D.F., and Dees, S.M., 2002. Mapping training: The transfer of a cognitive technology for improving counseling. Journal of Substance Abuse Treatment 22(4):219-230.

Joe, G.W., et al., 2002. Measuring patient attributes and engagement in treatment. Journal of Substance Abuse Treatment 22(4):183-196.

Lehman, W.E.; Greener, J.M.; and Simpson, D.D., 2002. Assessing organizational readiness for change. Journal of Substance Abuse Treatment 22(4):197-209.

National Institute on Drug Abuse, 2004. Blue Ribbon Task Force on NIDA Health Services Research. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health. Full Text Available

Roman, P.M., and Johnson, J.A., 2002. Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment. Abstract Available

Simpson, D.D., 2002. A conceptual framework for transferring research to practice. Journal of Substance Abuse Treatment 22(4):171-182. Abstract Available

Simpson, D.D., 2004. A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment 27(2):99-121. Abstract Available

One Program's Transition to Research-Based Strategies for Treating Methamphetamine Abuse
[PDF - 2.7MB]
Jay M. Hansen

[PDF - 92K]

Hser, Y.-I.; Evans, E.; and Huang, Y.-C., 2005. Treatment outcomes among women and men methamphetamine abusers in California. Journal of Substance Abuse Treatment 28(1):77-85.

Rawson, R.A., et al., 2004. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99(6):708-717. Abstract Available

Roll, J.M., et al., 2006. Contingency management for the treatment of methamphetamine use disorders. American Journal of Psychiatry 163(11):1993-1999.

Quality and Performance Improvement: What's a Program To Do?
[PDF - 136K]
Frank McCorry, Ph.D.

Fixsen, D.L., et al., 2005. Implementation research: A synthesis of the literature. Louis de la Parte Florida Mental Health Institute, National Implementation Research Network (FMHI Publication No. 231), Tampa, FL: University of South Florida. Full Text Available

Garnick, D.W., et al., 2002. Establishing the feasibility of performance measurement for alcohol and drug services. Journal of Substance Abuse Treatment 23(4):375-385.

Garnick, D.W.; Horgan, C.M.; and Chalk, M., 2006. Performance measures for alcohol and other drug services. Alcohol Research and Health 29(1):19-26. Abstract Available

McCorry, F., et al., 2000. Developing performance measures for alcohol and drug services in managed care plans. Joint Commission Journal on Quality Improvement 26(11):633-643. Abstract Available

Perrin, E.B.; Durch, J.S.; Skillman, S.M., 1999. Health Performance Measurement in the Public Sector, National Research Council. Washington, DC: National Academy Press. Full Text Available pdf

Attending to Emotional Cues for Drug Abuse: Bridging the Gap Between Clinic and Home Behaviors
[PDF - 136K]
Michael W. Otto, Ph.D., Conall M. O'Cleirigh, Ph.D., and Mark H. Pollack, M.D.

Ahlers, S.T., and Richardson, R., 1985. Administration of dexamethasone prior to training blocks ACTH-induced recovery of an extinguished avoidance response. Behavioral Neuroscience 99(4):760-764. Abstract Available

Beck, K.H., et al., 1995. Social context and sensation seeking: Gender differences in college student drinking motivations. International Journal of Addictions 30(9):1101-1115. Abstract Available

Bouton, M.E., 2002. Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biological Psychiatry 52(10):976-986. Abstract Available

Bouton, M.E.; Kenney, F.A.; and Rosengard, C., 1990. State-dependent fear extinction with two benzodiazepine tranquilizers. Behavioral Neuroscience 104(1):44-55. Abstract Available

Carroll, K.M., and Onken, L.S., 2005. Behavioral therapies for drug abuse. American Journal of Psychiatry 162(8):1452-1460.

Carter, B.L., and Tiffany, S.T., 1999. Meta-analysis of cue-reactivity in addiction research. Addiction 94(3):327-340. Abstract Available

Chaney, E.F.; Roszell, D.K.; and Cummings, C., 1982. Relapse in opiate addicts: A behavioral analysis. Addictive Behaviors 7(3):291-297.

Childress, A.R., et al., 1994. Can induced moods trigger drug-related responses in opiate abuse patients? Journal of Substance Abuse Treatment 11(1):17-23. Abstract Available

Collins, B.N., and Brandon, T.H., 2002. Effects of extinction context and retrieval cues on alcohol cue reactivity among nonalcoholic drinkers. Journal of Consulting and Clinical Psychology 70(2):390-397. Abstract Available

Crombag, H.S., and Shaham, Y., 2002. Renewal of drug seeking by contextual cues after prolonged extinction in rats. Behavioral Neuroscience 116(1):169-173. Abstract Available

Davidson, T.L., 1993. The nature and function of interoceptive signals to feed: Toward integration of physiological and learning perspectives. Psychology Review 100(4):640-657. Abstract Available

Drummond, D.C., and Glautier, S.P., 1994. A controlled trial of cue exposure treatment in alcohol dependence. Journal of Consulting and Clinical Psychology 62(4):809-817. Abstract Available

Franken, I.H.A., et al., 1999. Cue reactivity and effects of cue exposure in abstinent posttreatment drug users. Journal of Substance Abuse Treatment 16(1):81-85.

Fyer, A.J., et al., 1987. Discontinuation of alprazolam treatment in panic patients. American Journal of Psychiatry 144(3):303-308. Abstract Available

Garssen, B.; de Ruiter, C.; and van Dyck, R., 1992. Breathing retraining: A rational placebo? Clinical Psychology Review 12(2):141-153.

Hegel, M.T.; Ravaris, C.L.; and Ahles, T.A., 1994. Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy 25(2):183-195.

Hopko, D.R., et al., 2003. Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clinical Psychology Review 23(5):699-717.

Klajner, F.; Hartman, L.M.; and Sobell, M.B., 1984. Treatment of substance abuse by relaxation training: A review of its rationale, efficacy, and mechanisms. Addictive Behaviors 9(1):41-55.

Litt, M.D., et al., 1990. Reactivity to alcohol cues and induced moods in alcoholics. Addictive Behaviors 15(2):137-146.

Mellman, T.A., and Uhde, T.W., 1986. Withdrawal syndrome with gradual tapering of alprazolam. American Journal of Psychiatry 143(11):1464-1466. Abstract Available

Monti, P.M., et al., 1993. Alcohol cue reactivity: Effects of detoxification and extended exposure. Journal of Studies on Alcohol 54(2):235-245. Abstract Available

Mystkowski, J.L., et al., 2003. Changes in caffeine states enhance return of fear in spider phobia. Journal of Consulting and Clinical Psychology 71(2):243-250. Abstract Available

Noyes, R., et al., 1991. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry 148(4):517-523. Abstract Available

O'Brien, C.P., et al., 1990. Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addictive Behaviors 15(4):355-365. Abstract Available

O'Connell, K.A., and Martin, E.J., 1987. Highly tempting situations associated with abstinence, temporary lapse, and relapse among participants in smoking cessation programs. Journal of Consulting and Clinical Psychology 55(3):367-371. Abstract Available

Otto, M.W., 2000. Stories and metaphors in cognitive-behavior therapy. Cognitive and Behavioral Practice 7(2):166-172.

Otto, M.W., et al., 1993. Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavior therapy for patients with panic disorder. American Journal of Psychiatry 150(10):1485-1490. Abstract Available

Otto, M.W.; Hong, J.J.; and Safren, S.A., 2002. Benzodiazepine discontinuation difficulties in panic disorder: Conceptual model and outcome for cognitive-behavior therapy. Current Pharmaceutical Design 8(1):75-80. Full Text Available

Otto, M.W.; Safren, S.A.; and Pollack, M.H., 2004. Internal cue exposure and the treatment of substance use disorders: Lessons from the treatment of panic disorder. Journal of Anxiety Disorders 18(1):69-87.

Pollack, M.H., et al., 2002. A novel cognitive-behavioral approach for treatment-resistant drug dependence. Journal of Substance Abuse Treatment 23(4):335-342.

Powell, J.; Gray, J.; and Bradley, B.P., 1993. Subjective craving for opiates: Evaluation of a cue exposure protocol for use with detoxified opiate addicts. British Journal of Clinical Psychology 32(Pt. 1):39-53. Abstract Available

Robbins, S.J., et al., 2000. Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and Alcohol Dependence 59(1):33-42.

Rubonis, A.V., et al., 1994. Alcohol cue reactivity and mood induction in male and female alcoholics. Journal of Studies on Alcohol 55(4):487-494. Abstract Available

Sherman, J.E., et al., 1989. Subjective dimensions of heroin urges: Influence of heroin-related and affectively negative stimuli. Addictive Behaviors 14(6):611-623. Abstract Available

Spiegel, D.A., et al., 1994. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry 151(6):876-881. Abstract Available

Zvolensky, M. J., et al., 2001. Affective style among smokers: Understanding anxiety sensitivity, emotional reactivity, and distress tolerance using biological challenge. Addictive Behaviors 26(6):901-915.

- Issue Index
- Subscribe to the Journal

Get Adobe Reader

NIDA Addiction Science & Clinical Practice
Subscription Department
RTI International
1375 Piccard Drive, Suite 175
Rockville, MD 20850

Fax: (240) 632–0519


Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal